Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.